Berkshire Asset Management LLC PA trimmed its holdings in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 3.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 226,192 shares of the company's stock after selling 8,242 shares during the period. Procter & Gamble comprises about 1.4% of Berkshire Asset Management LLC PA's investment portfolio, making the stock its 29th largest holding. Berkshire Asset Management LLC PA's holdings in Procter & Gamble were worth $32,416,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Carson Advisory Inc. grew its stake in Procter & Gamble by 0.5% in the fourth quarter. Carson Advisory Inc. now owns 12,124 shares of the company's stock valued at $1,738,000 after acquiring an additional 65 shares during the period. Trilogy Capital Inc. grew its stake in Procter & Gamble by 1.1% in the fourth quarter. Trilogy Capital Inc. now owns 6,289 shares of the company's stock valued at $901,000 after acquiring an additional 67 shares during the period. Cary Street Partners Investment Advisory LLC grew its stake in Procter & Gamble by 1.8% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 3,829 shares of the company's stock valued at $549,000 after acquiring an additional 67 shares during the period. Lorne Steinberg Wealth Management Inc. grew its stake in Procter & Gamble by 2.7% in the fourth quarter. Lorne Steinberg Wealth Management Inc. now owns 2,623 shares of the company's stock valued at $376,000 after acquiring an additional 68 shares during the period. Finally, Grant Street Asset Management Inc. grew its stake in Procter & Gamble by 2.7% in the fourth quarter. Grant Street Asset Management Inc. now owns 2,627 shares of the company's stock valued at $376,000 after acquiring an additional 69 shares during the period. 65.77% of the stock is owned by institutional investors and hedge funds.
Procter & Gamble Stock Up 1.3%
PG stock opened at $152.38 on Wednesday. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.73 and a quick ratio of 0.53. The stock has a market capitalization of $354.83 billion, a P/E ratio of 22.28, a P/E/G ratio of 6.54 and a beta of 0.39. The business has a 50-day moving average of $144.96 and a 200-day moving average of $147.75. Procter & Gamble Company has a fifty-two week low of $137.62 and a fifty-two week high of $167.25.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings data on Friday, April 24th. The company reported $1.59 earnings per share for the quarter, topping the consensus estimate of $1.56 by $0.03. The company had revenue of $21.24 billion during the quarter, compared to analysts' expectations of $21.52 billion. Procter & Gamble had a return on equity of 32.00% and a net margin of 19.16%.Procter & Gamble's revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.54 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, sell-side analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, May 15th. Investors of record on Friday, April 24th were issued a dividend of $1.0885 per share. The ex-dividend date was Friday, April 24th. This is a boost from Procter & Gamble's previous quarterly dividend of $1.06. This represents a $4.35 annualized dividend and a yield of 2.9%. Procter & Gamble's dividend payout ratio is currently 63.60%.
Analyst Ratings Changes
PG has been the subject of a number of research analyst reports. Bank of America decreased their target price on Procter & Gamble from $171.00 to $167.00 and set a "buy" rating for the company in a research note on Friday, April 10th. Barclays decreased their target price on Procter & Gamble from $155.00 to $146.00 and set an "equal weight" rating for the company in a research note on Tuesday, April 14th. Morgan Stanley decreased their target price on Procter & Gamble from $175.00 to $166.00 and set an "overweight" rating for the company in a research note on Wednesday, April 22nd. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a $163.00 price objective on shares of Procter & Gamble in a research report on Monday, April 27th. Finally, Piper Sandler upped their price objective on Procter & Gamble from $142.00 to $145.00 and gave the stock a "neutral" rating in a research report on Friday, April 24th. Eleven investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $160.78.
Get Our Latest Report on PG
About Procter & Gamble
(
Free Report)
Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Featured Articles
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.
"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.